ELUT Class A Elutia, Inc. - Class A Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026
$0.78
· of 52w range
· above low
· to high
$0.5252w low
$1.3952w high
P/E (TTM)
0.8
EPS (TTM)
$1.00
Revenue (TTM)
$6M
your badges
52W Range
$1–$1
Analyst Rating
BUY
Price Target
$5
P/E
0.8
ROE
-397.0%
Net Profit Margin
935.0%
Your badge strip is empty — pin a metric anywhere on this page.
ELUT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.78
P/E (TTM)
0.8
EPS (TTM)
$1.00
Revenue (TTM)
$6M
ROE (TTM)
-397.0%
52W Range
$1–$1
ELUT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$12M2019-12-31 → 2025-12-31
EPS$0.872020-12-31 → 2025-12-31
Free Cash Flow$-47M2020-12-31 → 2025-12-31
Net margin935.0%2020-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ELUT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 0.85Y avg ≈-1.3 | ≈-1.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ELUT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 78.1%5Y avg ≈44.3% | ≈44.3% | · | · | |
| Operating Margin (TTM) | -422.6%5Y avg ≈-120.3% | ≈-120.3% | -295.7% | In line | |
| EBITDA Margin (TTM) | -391.9%5Y avg ≈-106.8% | ≈-106.8% | -295.7% | In line | |
| Pretax Margin (TTM) | -321.1%5Y avg ≈-127.3% | ≈-127.3% | -200.5% | Weak | |
| Net Profit Margin (TTM) | 935.0%5Y avg ≈-11.7% | ≈-11.7% | -178.5% | Weak | |
| ROA (TTM) | 133.7%5Y avg ≈-35.2% | ≈-35.2% | -30.5% | Top tier | |
| ROE (TTM) | -397.0%5Y avg ≈-66.3% | ≈-66.3% | 3.1% | Weak | |
| ROIC | -97.3%5Y avg ≈8.7% | ≈8.7% | -16.2% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ELUT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.85Y avg ≈1.3 | ≈1.3 | 0.8 | Strong liquidity | |
| Quick Ratio | 1.55Y avg ≈0.9 | ≈0.9 | 0.6 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | ELUT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -15.0%5Y avg ≈-18.3% | ≈-18.3% | · | · | |
| Revenue CAGR 3Y | -19.8%5Y avg ≈-23.0% | ≈-23.0% | · | · | |
| Revenue CAGR 5Y | -22.0% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ELUT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.25Y avg ≈0.5 | ≈0.5 | 0.1 | Top tier | |
| Inventory Turnover | 2.55Y avg ≈3.1 | ≈3.1 | · | · | |
| Receivables Turnover | 6.15Y avg ≈7.4 | ≈7.4 | 5.6 | In line | |
| Revenue / Employee | ≈$491.7K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
196.1%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $-0.17 | $-0.15 | -11.1% |
| March 31, 2026 | May 14, 2026 | $-0.17 | $-0.15 | -11.1% |
| Dec. 31, 2025 | $1.48 | $-0.14 | 1136.4% | |
| Sept. 30, 2025 | $-0.09 | $-0.16 | 43.1% | |
| June 30, 2025 | $-0.23 | $-0.17 | -32.6% | |
| March 31, 2025 | $-0.10 | $-0.21 | 52.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12M | $14M | $25M | $24M | $47M | $43M | $43M | |
| Cost of Revenue | $6M | $8M | $14M | $12M | $28M | $22M | $23M | |
| Gross Profit | $7M | $7M | $11M | $12M | $19M | $21M | $20M | |
| R&D Expense | $4M | $3M | $4M | $8M | $9M | $6M | $2M | |
| SG&A Expense | $15M | $18M | $14M | $16M | $14M | $11M | $10M | |
| Operating Expenses | $34M | $37M | $42M | $47M | $42M | $34M | $28M | |
| Operating Income | $-27M | $-31M | $-31M | $-35M | $-23M | $-14M | $-8M | |
| Interest Expense | · | · | $6M | $5M | $5M | $6M | $5M | |
| Other Non-op | $-3M | $1M | $-759.0K | $4M | $4M | $-3M | $2M | |
| Pretax Income | $-16M | $-45M | $-41M | $-36M | $-25M | $-22M | $-12M | |
| Income Tax | $13.0K | $7.0K | $28.0K | $34.0K | $55.0K | $26.0K | $30.0K | |
| Net Income | $53M | $-54M | $-38M | $-33M | $-25M | $-22M | $-12M | |
| EPS (Basic) | $1.29 | $-1.86 | $-2.07 | $-2.38 | $-2.38 | $-8.88 | · | |
| EPS (Diluted) | $0.87 | $-1.86 | $-2.07 | $-2.38 | $-2.38 | $-8.88 | · | |
| Shares (Basic) | 41,416,850 | 29,071,113 | 18,160,822 | 13,832,887 | 10,444,767 | 2,852,541 | · | |
| Shares (Diluted) | 45,942,787 | 29,071,113 | 18,160,822 | 13,832,887 | 10,444,767 | 2,852,541 | · | |
| EBITDA | $-24M | $-32M | $-27M | $-28M | $-19M | $-10M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $36M | $13M | $19M | $17M | $30M | $39M | $2M | |
| Receivables | $2M | $2M | $3M | $4M | $6M | $7M | $7M | |
| Inventory | $3M | $2M | $4M | $4M | $10M | $10M | $7M | |
| Prepaid Expense | $2M | $2M | $2M | $2M | $1M | $3M | $1M | |
| Current Assets | $56M | $26M | $31M | $51M | $47M | $60M | $18M | |
| PP&E (Net) | $3M | $671.0K | $172.0K | $245.0K | $1M | $1M | $988.0K | |
| PP&E (Gross) | $3M | $892.0K | $753.0K | $830.0K | $6M | $6M | $5M | |
| Accum. Depreciation | $283.0K | $221.0K | $581.0K | $585.0K | $4M | $4M | $4M | |
| Intangibles | $2M | $3M | $12M | $15M | $18M | $22M | $25M | |
| Other Non-current Assets | $2M | $179.0K | $332.0K | $320.0K | $76.0K | $76.0K | $76.0K | |
| Total Assets | $62M | $36M | $43M | $69M | $67M | $83M | $45M | |
| Accounts Payable | $5M | $4M | $3M | $1M | $2M | $2M | $2M | |
| Accrued Liabilities | $4M | $7M | $9M | $9M | $6M | $6M | $4M | |
| Short-term Debt | · | $1M | $3M | · | $8M | $6M | $2M | |
| Current Liabilities | $25M | $38M | $43M | $43M | $26M | $27M | $18M | |
| Capital Leases | $4M | $16.0K | · | $956.0K | · | · | · | |
| Other Non-current Liabilities | · | · | $515.0K | $127.0K | $698.0K | $756.0K | · | |
| Total Liabilities | $35M | $82M | $82M | $74M | $54M | $62M | $55M | |
| Long-term Debt | · | $24M | $24M | · | $18M | $24M | $21M | |
| Total Debt | · | $24M | $24M | $24M | $27M | $30M | · | |
| Common Stock | · | · | · | · | · | · | $1.0K | |
| Paid-in Capital | $204M | $183M | $137M | $133M | $119M | $101M | $2M | |
| Retained Earnings | $-176M | $-230M | $-176M | $-138M | $-105M | $-80M | $-57M | |
| Stockholders' Equity | $28M | $-46M | $-39M | $-5M | $14M | $21M | $-55M | |
| Liabilities + Equity | $62M | $36M | $43M | $69M | $67M | $83M | $45M | |
| Shares Outstanding | · | · | · | · | · | · | 648,277 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $4M | $4M | $4M | $4M | $4M | |
| Stock-based Comp | $5M | $8M | $2M | $4M | $4M | $779.0K | $208.0K | |
| Amort. of Intangibles | $1M | $1M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-cash | $-106M | $20M | $10M | $4M | $2M | $4M | · | |
| Operating Cash Flow | $-45M | $-23M | $-22M | $-21M | $-15M | $-14M | $-7M | |
| CapEx | $2M | $654.0K | $346.0K | $540.0K | $369.0K | $640.0K | $577.0K | |
| Investing Cash Flow | $79M | $-474.0K | $14M | $-540.0K | $-369.0K | $-640.0K | $-577.0K | |
| Net Debt Issued | · | · | · | $-19M | $-3M | $-300.0K | · | |
| Financing Cash Flow | $-11M | $17M | $10M | $9M | $7M | $51M | $8M | |
| Taxes Paid | · | · | · | · | · | $32.0K | $25.0K | |
| Free Cash Flow | $-47M | $-23M | $-22M | $-22M | $-16M | $-14M | · | |
| Levered FCF | · | · | $-28M | $-27M | $-21M | $-20M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.7% | 43.9% | 44.7% | 39.1% | 40.1% | 48.2% | · | |
| Operating Margin | -218.9% | -146.3% | -123.4% | -64.5% | -48.6% | -31.9% | · | |
| Net Margin | 434.2% | -221.3% | -152.2% | -66.9% | -52.4% | -51.1% | · | |
| Pretax Margin | -129.0% | -222.0% | -166.6% | -66.8% | -52.3% | -51.1% | · | |
| EBITDA Margin | -196.3% | -132.1% | -108.2% | -56.9% | -40.7% | -22.8% | · | |
| ROA | 108.4% | -135.6% | -67.1% | -48.4% | -33.1% | -34.2% | · | |
| ROE | -753.4% | 124.7% | 110.6% | 418.7% | -232.3% | 80.7% | · | |
| ROIC | -97.3% | 159.1% | 204.7% | -165.2% | -57.6% | -26.6% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 0.7 | 0.7 | 1.2 | 1.8 | 2.2 | · | |
| Quick Ratio | 1.5 | 0.4 | 0.5 | 0.6 | 1.4 | 1.7 | · | |
| Debt / Equity | · | -0.5 | -0.6 | -4.8 | 2.0 | 1.5 | · | |
| LT Debt / Equity | · | -0.5 | -0.5 | -4.8 | 0.8 | 0.9 | · | |
| Interest Coverage | · | · | -5.3 | -6.0 | -4.3 | -2.4 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.6 | 0.4 | 0.7 | 0.6 | 0.7 | · | |
| Inventory Turnover | 2.5 | 3.5 | 3.4 | 3.1 | 2.9 | 2.6 | · | |
| Receivables Turnover | 6.1 | 8.8 | 7.0 | 7.7 | 7.2 | 5.9 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.27 | $0.84 | $1.36 | $3.56 | $4.54 | · | · | |
| Cash Flow / Share | $-0.98 | $-0.78 | $-1.20 | $-1.55 | $-1.48 | · | · | |
| EPS (TTM) | $0.87 | $-1.86 | $-2.07 | $-2.38 | $-2.38 | $-8.88 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -15.0% | -41.5% | 3.8% | -49.7% | 11.0% | · | · | |
| Revenue CAGR 3Y | -19.8% | -32.7% | -16.6% | · | · | · | · | |
| Revenue CAGR 5Y | -22.0% | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12M | $14M | $25M | $24M | $47M | $43M | · | |
| Net Income TTM | $53M | $-54M | $-38M | $-33M | $-25M | $-22M | · | |
| P/E | 0.8 | -2.0 | -1.0 | -1.8 | -2.6 | -1.5 | · | |
| Earnings Yield | 125.5% | -49.7% | -95.8% | -56.0% | -37.8% | -65.1% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $3M | $-3M | $3M | $3M | $3M | $-2M | $4M | $6M | $7M | $6M | $6M | $6M | $6M | $-6M | $6M | |
| Cost of Revenue | $980.0K | $1M | $-3M | $1M | $1M | $2M | $-1M | $2M | $3M | $4M | $4M | $3M | $4M | $3M | $-6M | $3M | |
| Gross Profit | $1M | $2M | $-772.0K | $2M | $1M | $1M | $-718.0K | $2M | $3M | $3M | $2M | $3M | $3M | $3M | $-479.0K | $3M | |
| R&D Expense | $3M | $2M | $714.0K | $1M | $989.0K | $871.0K | $123.0K | $702.0K | $1M | $1M | $1M | $557.0K | $869.0K | $2M | $1M | $2M | |
| SG&A Expense | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $3M | $4M | $4M | $3M | $4M | |
| Operating Expenses | $9M | $8M | $3M | $7M | $10M | $8M | $4M | $11M | $11M | $11M | $11M | $10M | $9M | $12M | $11M | $12M | |
| Operating Income | $-8M | $-6M | $-4M | $-5M | $-8M | $-7M | $-5M | $-9M | $-9M | $-8M | $-9M | $-7M | $-6M | $-8M | $-11M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | $2M | $1M | $1M | $1M | |
| Other Non-op | $58.0K | $71.0K | $-1M | $0 | $-1M | $-105.0K | $0 | $0 | $-257.0K | $1M | $-1.0K | $-758.0K | · | · | $5M | $-803.0K | |
| Pretax Income | $-8M | $-8M | $-2M | $-375.0K | $-7M | $-2M | $-2M | $3M | $-28M | $-18M | $-15M | $-9M | $-8M | $-10M | $-8M | $-11M | |
| Income Tax | $8.0K | $70.0K | $-11.0K | $8.0K | $8.0K | $8.0K | $2.0K | $8.0K | $-11.0K | $8.0K | $-8.0K | $12.0K | $12.0K | $12.0K | $-2.0K | $12.0K | |
| Net Income | $-8M | $-7M | $71M | $-4M | $-10M | $-4M | $-9M | $1M | $-28M | $-18M | $-9M | $-10M | $-11M | $-8M | $-5M | $-10M | |
| EPS (Basic) | $-0.17 | $-0.17 | $1.71 | $-0.09 | $-0.23 | $-0.10 | $-0.01 | $0.03 | $-1.13 | $-0.75 | $-0.36 | $-0.57 | $-0.65 | $-0.49 | $-0.36 | $-0.73 | |
| EPS (Diluted) | $-0.17 | $-0.17 | $1.53 | $-0.19 | $-0.26 | $-0.21 | $0.35 | $-0.33 | $-1.13 | $-0.75 | $-0.36 | $-0.57 | $-0.65 | $-0.49 | $-0.36 | $-0.73 | |
| Shares (Basic) | 44,223,722 | 42,998,504 | · | 42,431,314 | 41,782,556 | 38,616,207 | · | 32,520,134 | 24,900,167 | 23,912,326 | · | 17,017,610 | 16,223,919 | 16,149,567 | · | 13,660,555 | |
| Shares (Diluted) | 44,223,722 | 42,998,504 | · | 46,957,199 | 46,308,642 | 42,913,111 | · | 35,520,938 | 24,900,167 | 23,912,326 | · | 17,017,610 | 16,223,919 | 16,149,567 | · | 13,660,555 | |
| EBITDA | $-8M | $-6M | · | $-5M | $-10M | $-7M | · | $-10M | $-9M | $-8M | · | $-7M | $-9M | $-5M | · | $-8M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $28M | $36M | $5M | $8M | $17M | $13M | $26M | $18M | $13M | $19M | $15M | $9M | $12M | $17M | $8M | |
| Receivables | $1M | $2M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $4M | $3M | $3M | $6M | $7M | $4M | $7M | |
| Inventory | $3M | $3M | $3M | $2M | $5M | $4M | $2M | $4M | $3M | $3M | $4M | $7M | $9M | $11M | $4M | $10M | |
| Prepaid Expense | $1M | $2M | $2M | $539.0K | $1M | $2M | $2M | $431.0K | $1M | $2M | $2M | $452.0K | $2M | $2M | $2M | $970.0K | |
| Current Assets | $37M | $49M | $56M | $18M | $22M | $30M | $26M | $37M | $30M | $24M | $31M | $39M | $36M | $43M | $51M | $44M | |
| PP&E (Net) | $3M | $3M | $3M | $2M | $2M | $1M | $671.0K | $693.0K | $159.0K | $171.0K | $172.0K | $175.0K | $1M | $1M | $245.0K | $1M | |
| PP&E (Gross) | · | · | $3M | · | · | · | $892.0K | · | · | · | $753.0K | · | · | · | $830.0K | · | |
| Accum. Depreciation | · | · | $283.0K | · | · | · | $221.0K | · | · | · | $581.0K | · | · | · | $585.0K | · | |
| Intangibles | $990.0K | $1M | $2M | $2M | $7M | $7M | $3M | $9M | $10M | $11M | $12M | $13M | $13M | $14M | $15M | $16M | |
| Other Non-current Assets | $3M | $2M | $2M | $3M | $3M | $826.0K | $179.0K | $1M | $1M | $383.0K | $332.0K | $155.0K | $1M | $1M | $320.0K | $89.0K | |
| Total Assets | $44M | $55M | $62M | $29M | $34M | $39M | $36M | $48M | $42M | $35M | $43M | $55M | $52M | $61M | $69M | $61M | |
| Accounts Payable | $4M | $4M | $5M | $7M | $6M | $5M | $4M | $5M | $3M | $4M | $3M | $3M | $3M | $3M | $1M | $3M | |
| Accrued Liabilities | $5M | $6M | $4M | $7M | $6M | $6M | $7M | $5M | $7M | $9M | $9M | $11M | $12M | $9M | $9M | $9M | |
| Short-term Debt | · | · | · | $5M | $4M | $2M | $1M | · | $3M | $2M | $3M | · | · | · | · | · | |
| Current Liabilities | $21M | $24M | $25M | $41M | $38M | $37M | $38M | $40M | $40M | $38M | $43M | $45M | $43M | $41M | $43M | $40M | |
| Capital Leases | $4M | $4M | $4M | $3M | $3M | $319.0K | $16.0K | · | · | · | · | · | $711.0K | $835.0K | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $2M | $2M | $694.0K | $515.0K | $433.0K | $351.0K | $207.0K | $127.0K | $86.0K | |
| Total Liabilities | $28M | $33M | $35M | $73M | $76M | $76M | $82M | $89M | $106M | $86M | $82M | $84M | $74M | $73M | $74M | $72M | |
| Long-term Debt | · | · | · | $26M | $25M | $24M | · | $23M | $22M | $22M | · | · | · | · | · | $20M | |
| Total Debt | · | · | · | $31M | $29M | $27M | · | $23M | $26M | · | · | $25M | $25M | $25M | · | $20M | |
| Paid-in Capital | $207M | $206M | $204M | $203M | $201M | $197M | $183M | $180M | $157M | $143M | $137M | $137M | $134M | $134M | $133M | $122M | |
| Retained Earnings | $-191M | $-184M | $-176M | $-247M | $-243M | $-234M | $-230M | $-221M | $-222M | $-194M | $-176M | $-166M | $-157M | $-146M | $-138M | $-133M | |
| Stockholders' Equity | $16M | $23M | $28M | $-44M | $-42M | $-36M | $-46M | $-40M | $-64M | $-50M | $-39M | $-29M | $-22M | $-12M | $-5M | $-11M | |
| Liabilities + Equity | $44M | $55M | $62M | $29M | $34M | $39M | $36M | $48M | $42M | $35M | $43M | $55M | $52M | $61M | $69M | $61M |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $349.0K | $330.0K | $297.0K | $728.0K | $892.0K | $868.0K | $863.0K | $862.0K | $862.0K | $864.0K | $894.0K | $953.0K | $954.0K | $947.0K | $937.0K | $933.0K | |
| Stock-based Comp | $905.0K | $931.0K | $872.0K | $2M | $1M | $1M | $1M | $2M | $3M | $2M | $450.0K | $616.0K | $687.0K | $684.0K | $774.0K | $298.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | $-1M | $849.0K | $849.0K | $849.0K | $853.0K | $849.0K | $849.0K | $849.0K | $853.0K | $849.0K | |
| Other Non-cash | · | $-2M | · | · | · | $-7M | · | · | · | $12M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-8M | $-8M | $-25M | $-3M | $-8M | $-9M | $-12M | $-3M | $-4M | $-3M | $-9M | $-5M | $-2M | $-5M | $-5M | $-6M | |
| CapEx | $91.0K | $459.0K | $854.0K | $630.0K | $114.0K | $278.0K | $94.0K | $547.0K | $-2.0K | $15.0K | $17.0K | $62.0K | $85.0K | $182.0K | $134.0K | $117.0K | |
| Investing Cash Flow | $-91.0K | $-34.0K | $80M | $-630.0K | $-114.0K | $-278.0K | $-94.0K | $-547.0K | $182.0K | $-15.0K | $15M | $-62.0K | $-85.0K | $-182.0K | $-134.0K | $-117.0K | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $-2M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | $0 | $0 | $14M | · | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $14M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-40.0K | $3.0K | $-23M | $-262.0K | $-516.0K | $13M | $-151.0K | $12M | $10M | $-4M | $-695.0K | $10M | $-19.0K | $148.0K | $14M | $-3M | |
| Free Cash Flow | · | $-8M | · | · | · | $-9M | · | · | · | $-3M | · | · | · | $-5M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-4M | · | · | · | $-7M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.6% | 57.9% | · | 55.8% | 48.8% | 40.8% | · | 46.3% | 44.5% | 42.5% | · | 46.4% | 9.5% | 48.5% | · | 40.8% | |
| Operating Margin | -327.9% | -203.8% | · | -156.7% | -157.7% | -131.4% | · | -172.8% | -135.3% | -126.7% | · | -120.3% | -88.2% | -49.2% | · | -62.9% | |
| Net Margin | -315.0% | -239.8% | · | -116.4% | -153.4% | -65.2% | · | 21.7% | -447.9% | -268.8% | · | -159.1% | -103.2% | -61.1% | · | -80.0% | |
| Pretax Margin | -314.7% | -251.3% | · | -11.3% | -153.3% | -65.1% | · | 21.9% | -451.0% | -268.7% | · | -138.8% | -103.0% | -61.0% | · | -79.9% | |
| EBITDA Margin | -327.9% | -193.3% | · | -156.7% | -157.7% | -117.0% | · | -172.8% | -135.3% | -113.8% | · | -120.3% | -88.2% | -41.9% | · | -62.9% | |
| ROA | -19.7% | -15.8% | · | -9.9% | -25.4% | -7.9% | · | 3.1% | -59.8% | · | · | -16.9% | -20.2% | -13.2% | · | -16.4% | |
| ROE | 58.6% | 107.2% | · | 9.2% | 18.1% | 16.2% | · | -2.8% | 65.2% | · | · | 48.5% | 90.4% | 284.0% | · | 702.3% | |
| ROIC | -50.6% | -28.4% | · | 41.5% | 76.2% | 81.9% | · | 57.8% | 22.1% | · | · | 176.0% | -324.9% | -51.8% | · | -83.7% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 2.0 | · | 0.4 | 0.6 | 0.8 | · | 0.9 | 0.8 | · | · | 0.9 | 0.8 | 1.0 | · | 1.1 | |
| Quick Ratio | 1.0 | 1.3 | · | 0.2 | 0.3 | 0.5 | · | 0.7 | 0.5 | · | · | 0.4 | 0.4 | 0.5 | · | 0.4 | |
| Debt / Equity | · | · | · | -0.7 | -0.7 | -0.7 | · | -0.6 | -0.4 | · | · | -0.9 | -1.1 | -2.0 | · | -1.9 | |
| LT Debt / Equity | · | · | · | -0.5 | -0.5 | -0.6 | · | -0.6 | -0.3 | · | · | -0.9 | -1.1 | -2.0 | · | -1.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -6.5 | · | -5.1 | -6.0 | -4.2 | · | -6.0 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | 0.1 | · | · | 0.1 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.2 | 0.4 | · | 0.5 | 0.8 | 0.5 | · | 1.0 | 0.6 | · | · | 0.4 | 1.0 | 0.6 | · | 0.7 | |
| Receivables Turnover | 1.1 | 1.3 | · | 1.0 | 1.9 | 1.2 | · | 1.6 | 1.3 | · | · | 1.2 | 1.6 | 2.0 | · | 2.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.05 | $0.07 | · | $0.07 | $0.14 | $0.14 | · | $0.17 | $0.25 | $0.28 | · | $0.36 | $0.63 | $0.81 | · | $0.91 | |
| Cash Flow / Share | · | $-0.18 | · | · | · | $-0.21 | · | · | · | $-0.11 | · | · | · | $-0.32 | · | · | |
| EPS (TTM) | $1.00 | $0.91 | · | $-0.31 | $-0.45 | $-1.32 | · | $-2.57 | $-2.81 | $-2.33 | · | $-2.07 | $-2.23 | $-2.27 | · | $-2.86 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $6M | · | $7M | $7M | $11M | · | $23M | $25M | $25M | · | $13M | $12M | $19M | · | $41M | |
| Net Income TTM | $52M | $50M | · | $-26M | $-21M | $-40M | · | $-54M | $-65M | $-48M | · | $-34M | $-34M | $-33M | · | $-37M | |
| P/E | 1.0 | 1.2 | · | -2.9 | -4.4 | -1.9 | · | -1.5 | -1.8 | -1.4 | · | -0.7 | -1.1 | -0.7 | · | -2.5 | |
| Earnings Yield | 102.0% | 86.7% | · | -34.8% | -22.7% | -52.2% | · | -67.5% | -56.6% | -74.0% | · | -144.8% | -94.5% | -150.3% | · | -39.7% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $12M | $14M | $25M | $24M | $47M |
| Gross Margin % | 53.7% | 43.9% | 44.7% | 39.1% | 40.1% |
| Operating Margin % | -218.9% | -146.3% | -123.4% | -64.5% | -48.6% |
| Net Income | $53M | $-54M | $-38M | $-33M | $-25M |
| Diluted EPS | $0.87 | $-1.86 | $-2.07 | $-2.38 | $-2.38 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | -0.5 | -0.6 | -4.8 | 2.0 |
| Current Ratio | 2.2 | 0.7 | 0.7 | 1.2 | 1.8 |
| Quick Ratio | 1.5 | 0.4 | 0.5 | 0.6 | 1.4 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-47M | $-23M | $-22M | $-22M | $-16M |
Institutional owners (13F) 40 filers · $14.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
40
Value held
$14.5M
New positions
8
Exited positions
4
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 8 (0 vs prior Q) | 4 (0 vs prior Q) | 9 (+1 vs prior Q) | 7 (-3 vs prior Q) | -804K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | $3,119,974 | 3,184,947 | 21.48% | Shares |
| AIGH Capital Management LLC | $2,640,653 | 2,695,644 | 18.18% | Shares |
| Knollwood Investment Advisory, LLC | $2,504,567 | 2,556,724 | 17.24% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $2,148,243 | 2,192,980 | 14.79% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,119,724 | 1,142,575 | 7.71% | Shares |
| VANGUARD GROUP INC | $802,136 | 1,157,484 | 5.52% | Shares |
| PERKINS CAPITAL MANAGEMENT INC | $379,934 | 694,094 | 2.62% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $279,437 | 285,229 | 1.92% | Shares |
| Corient Private Wealth LP | $248,329 | 253,500 | 1.71% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $197,699 | 201,816 | 1.36% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $168,997 | 172,446 | 1.16% | Shares |
| BlackRock, Inc. | $164,433 | 167,857 | 1.13% | Shares |
| Birchview Capital, LP | $161,726 | 165,094 | 1.11% | Shares |
| CITADEL ADVISORS LLC | $120,985 | 123,505 | 0.83% | Shares |
| Rossmore Private Capital | $117,552 | 120,000 | 0.81% | Shares |
| XTX Topco Ltd | $51,533 | 52,606 | 0.35% | Shares |
| JANE STREET GROUP, LLC | $43,785 | 44,697 | 0.30% | Shares |
| NORTHERN TRUST CORP | $43,759 | 44,670 | 0.30% | Shares |
| Atom Investors LP | $43,329 | 44,231 | 0.30% | Shares |
| LRI Investments, LLC | $24,709 | 25,224 | 0.17% | Shares |
| BROWN ADVISORY INC | $19,724 | 20,135 | 0.14% | Shares |
| Verdence Capital Advisors LLC | $19,014 | 19,410 | 0.13% | Shares |
| Qube Research & Technologies Ltd | $16,825 | 17,175 | 0.12% | Shares |
| Indie Asset Partners, LLC | $12,355 | 12,612 | 0.09% | Shares |
| Fund Evaluation Group, LLC | $12,347 | 12,612 | 0.08% | Shares |
| STATE STREET CORP | $11,725 | 11,969 | 0.08% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $11,293 | 11,528 | 0.08% | Shares |
| Family Manage LLC | $9,840 | 10,045 | 0.07% | Shares |
| MARATHON CAPITAL MANAGEMENT | $9,796 | 10,000 | 0.07% | Shares |
| Vanguard Global Advisers, LLC | $7,977 | 8,140 | 0.05% | Shares |
| MORGAN STANLEY | $6,829 | 6,971 | 0.05% | Shares |
| WELLS FARGO & COMPANY/MN | $4,898 | 5,000 | 0.03% | Shares |
| UBS Group AG | $1,089 | 1,111 | 0.01% | Shares |
| Tower Research Capital LLC (TRC) | $751 | 767 | 0.01% | Shares |
| BARCLAYS PLC | $380 | 388 | 0.00% | Shares |
| GSA CAPITAL PARTNERS LLP | $88 | 89,386 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $54 | 55 | 0.00% | Shares |
| Tufton Capital Management | $14 | 14,550 | 0.00% | Shares |
| Virtu Financial LLC | $11 | 10,936 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Partners QP II, L.P., HighCape Partners GP II, L.P., HighCape Partners GP II, LLC, Kevin Rakin | Dec. 15, 2025 | 13.00% | Amendment | Passive investment | SEC |
| HighCape Capital, L.P., HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, HighCape Partners II, L.P., HighCape Partners QP II, L.P., HighCape Partners GP II, L.P., HighCape Partners GP II, LLC, W. Matthew Zuga, Kevin Rakin ×5 filings | March 13, 2025 | 26.40% | Amendment | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 14 insiders · 8 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Randal C Mills | PRESIDENT AND CEO | Sept. 10, 2026 M | 464,395 | 5 | 0 | $14,640 |
| Ronald K. Lloyd | PRESIDENT AND CEO | March 8, 2022 A | 31,775 | 0 | 0 | $0 |
| Matthew Ferguson | CHIEF FINANCIAL OFFICER | Sept. 10, 2026 M | 489,903 | 3 | 0 | $38,410 |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Sept. 10, 2026 M | 126,283 | 0 | 0 | $0 |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | March 8, 2023 M | 17,917 | 0 | 0 | $0 |
| Jerome Riebman | CHIEF MEDICAL OFFICER | Sept. 8, 2022 M | 14,989 | 0 | 0 | $0 |
| Peter G Edwards | GENERAL COUNSEL | Sept. 8, 2022 M | 3,498 | 0 | 0 | $0 |
| Darryl Roberts | EVP, OPERATIONS & PRODUCT DEV. | March 8, 2022 A | 3,329 | 0 | 0 | $0 |
| David Colpman | Director | June 11, 2026 A | 31,098 | 2 | 0 | $17,845 |
| Brigid Makes | Director | June 11, 2026 A | 27,000 | 1 | 0 | $13,000 |
| Guido J Neels | Director | June 11, 2026 A | 125,000 | 3 | 0 | $52,600 |
| Kevin Rakin | Director | June 11, 2026 A | 4,978,978 | 0 | 0 | $0 |
| Maybelle Jordan | Director | May 29, 2025 A | · | 0 | 0 | $0 |
| Matt Zuga | Director | May 29, 2025 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
ELUT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$5.00
+542.1%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-09-30Mean target $5.00 +542.1%
Low$5.00
Mean$5.00
High$5.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026